LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,668 | 21,221 | 87,820 | 172,600 | 90,915 |
| Receivables | 8,610 | 5,834 | 2,960 | 1,381 | N/A |
| Inventories | 6,281 | 6,013 | 2,211 | 2,020 | N/A |
| Other current assets | 0 | 0 | 0 | 4 | 0 |
| TOTAL | $67,315 | $36,456 | $97,458 | $181,116 | $94,062 |
| Non-Current Assets | |||||
| PPE Net | 113 | 215 | 18,389 | 22,267 | 24,568 |
| Intangibles | 33,444 | 34,996 | 0 | 0 | 0 |
| Other Non-Current Assets | 358 | 576 | 16,400 | 909 | 909 |
| TOTAL | $33,915 | $35,787 | $34,789 | $23,176 | $25,477 |
| Total Assets | $101,230 | $72,243 | $132,247 | $204,292 | $119,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,278 | 2,762 | 4,177 | 8,572 | 11,484 |
| Accrued Expenses | 10,029 | 9,184 | 17,644 | 15,994 | 5,698 |
| Other current liabilities | 2,325 | N/A | N/A | N/A | N/A |
| TOTAL | $17,635 | $12,338 | $24,587 | $25,936 | $18,552 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,849 | 188 | N/A | 1,370 | 1,370 |
| Other Non-Current Liabilities | 25,830 | 23,555 | 39,271 | 4,503 | 0 |
| TOTAL | $150,333 | $147,992 | $163,650 | $142,435 | $12,785 |
| Total Liabilities | $167,968 | $160,330 | $188,237 | $168,371 | $31,337 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,962 | 27,428 | 27,215 | 27,076 | 22,168 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -1,057,092 | -1,076,752 | -1,037,331 | -920,983 | -721,514 |
| Other shareholders' equity | 3,906 | 3,906 | 3,906 | 6,643 | 6,643 |
| TOTAL | $-66,738 | $-88,087 | $-55,990 | $35,921 | $88,202 |
| Total Liabilities And Equity | $101,230 | $72,243 | $132,247 | $204,292 | $119,539 |